Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c77ae05fab05f218546f0b11e53af97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38f39fae163f8547c8a8e94cec5f1605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd8386dcd83f057d55cfe8b425d5e153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17da959900cda55cd08a06debfef9040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c08eacd1bde0ff886dbb7529dec45cd9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0648 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61G10-026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61G10-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
filingDate |
2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc668e68ecb3c301c94c4657b166bfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c39f584c96e99ed238bb54d425a54822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ec72b4e0bb808e53852887cb3ecfc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5af72d95813441e442f10289a1e8f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0831ff438bdf35bbf57a7919b2b0c96 |
publicationDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019054312-A1 |
titleOfInvention |
Method of Noninvasive Treatment of Diabetic Retinopathy |
abstract |
A method for noninvasive treatment of diabetic retinopathy helps prevent and reverses diabetic retinopathy and other vascular retinopathies, such as diabetic macular edema for a patient. The method comprises administering at least 80 percent pure oxygen to a patient in an oxygen chamber or nasal cannula. The oxygen chamber includes light emitting diodes that emit a light having a wavelength between 630-700 nm wavelengths on the patient. The method also includes administering an anti-inflammatory agent; an anti-oxidant; at least one of the following: an amino acid, arginine, and citrulline; and an omega-3 fatty acids to the patient. In extreme cases of diabetic retinopathy, a cold laser therapy is also administered to the patient with a wavelength between 570 nanometers and 1000 nanometers. The combination of all the aforementioned treatment modalities and compositions that work to synergistically to achieve unexpected clinical results for prevention and reversal of diabetic retinopathy. |
priorityDate |
2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |